Pharsight

Qvar 40 patents expiration

QVAR 40 IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5605674 TEVA BRANDED PHARM Medicinal aerosol formulations
Feb, 2014

(10 years ago)

US5683677 TEVA BRANDED PHARM Medicinal aerosol formulations
Nov, 2014

(9 years ago)

US5776432 TEVA BRANDED PHARM Beclomethasone solution aerosol formulations
Jul, 2015

(8 years ago)

US6446627 TEVA BRANDED PHARM Inhaler dose counter
Dec, 2017

(6 years ago)

US10695512 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(6 years from now)

US9463289 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
May, 2031

(6 years from now)

US10022509 TEVA BRANDED PHARM Dose counter for inhaler having a bore and shaft arrangement
May, 2031

(6 years from now)

US10086156 TEVA BRANDED PHARM Dose counter for inhaler and method for counting doses
May, 2031

(6 years from now)

US10022510 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
May, 2031

(6 years from now)

US11395889 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(6 years from now)

US9808587 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(6 years from now)

US10561808 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
Jan, 2032

(7 years from now)

Qvar 40 is owned by Teva Branded Pharm.

Qvar 40 contains Beclomethasone Dipropionate.

Qvar 40 has a total of 12 drug patents out of which 4 drug patents have expired.

Expired drug patents of Qvar 40 are:

  • US5605674
  • US5683677
  • US5776432
  • US6446627

Qvar 40 was authorised for market use on 15 September, 2000.

Qvar 40 is available in aerosol, metered;inhalation dosage forms.

The generics of Qvar 40 are possible to be released after 01 January, 2032.

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using BECLOMETHASONE DIPROPIONATE ingredient

Market Authorisation Date: 15 September, 2000

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

How can I launch a generic of QVAR 40 before it's drug patent expiration?
More Information on Dosage

QVAR 40 family patents

Family Patents